Article metrics

Download PDFPDF

Correction: Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial

 

Online download statistics by month:

Online download statistics by month: May 2021 to December 2021

AbstractFullPdf
May 20210337111
Jun 202109122
Jul 202108225
Aug 20210907
Sep 20210689
Oct 202106429
Nov 202106020
Dec 20210665
Total0858228